EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Using machine learning to predict clinical remission with exclusive enteral nutrition in pediatric Crohn disease

Ricardo G Suarez Suarez iD, Daniel G McClement, Roberto Vega, Hien Q Huynh, Ayub Shaikh, Anthony Otley, Kevan Jacobson, Mary Sherlock, David R Mack, Colette Deslandres, Wael El-Matary, Eileen Crowley und 6 weitere

Journal of Pediatric Gastroenterology and Nutrition · 2026

DOI: 10.1002/jpn3.70299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2026. Verfasst von Ricardo G Suarez Suarez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Crohn Disease, Enteral Nutrition, Machine Learning. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR), Children with Intestinal and Liver Disorders (Ch.I.L.D.) Foundation, The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Exclusive enteral nutrition (EEN) is a first‐line treatment for induction of remission in luminal pediatric Crohn disease (pCD). However, as the efficacy of EEN varies from patient to patient, there is a need to distinguish between responders and nonresponding patients. This study had two aims. First, to develop a model to predict EEN‐induced clinical remission (weighted pediatric CD activity index [wPCDA] ≤ 12.5) using baseline clinical information. Second, to develop a model to predict corticosteroid‐free sustained clinical remission post‐EEN induction (wPCDA ≤ 12.5, for ≥36 weeks after EEN).

Methods

We applied machine learning to clinical and laboratory data from a prospectively followed cohort of pCD patients who received EEN as their first treatment for CD ( n = 308). This learning algorithm used feature selection and k‐fold (internal) cross‐validation to systematically find the model with the best combination of features and hyperparameter settings. To estimate the quality of the learned model, we used k‐fold (external) cross‐validation.

Results

Clinical, laboratory, and treatment data were compiled into two different datasets: EEN clinical remission at the end of EEN treatment (mean of 60 days; n = 114) and corticosteroid‐free sustained clinical remission post‐EEN induction ( n = 206). Our resulting models were effective, with external area under the curves of 0.65 0.015 and 0.60 0.018. Moreover, a permutation label test showed that our learning process was stable and significantly different from chance, at p ‐values of 0.002 and 0.01, respectively.

Conclusion

Our models, based on accessible clinical features, were able to effectively predict EEN success above chance. This supports the plausibility of building clinical tools to assist precision therapy for pCD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseEnteral NutritionMachine LearningHumansRemission InductionChildMaleFemaleAdolescentProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

classification taskmodel selecting learnernutritional therapypersonalized medicinetreatment response

Autor:innen und Institutionen

  • Department of Paediatrics, University of Alberta, Edmonton, Alberta, Canada.
  • Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada.
  • SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada.
  • Department of Pediatrics, Division of Gastroenterology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Department of Paediatrics, Division of Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Division of Paediatrics, Faculty of Health Sciences McMaster University, Hamilton, Ontario, Canada.

ORCID-Profile: Ricardo G Suarez Suarez, Russell Greiner, Eytan Wine

Förderung

  • Canadian Institutes of Health Research (CIHR)
  • Children with Intestinal and Liver Disorders (Ch.I.L.D.) Foundation
  • The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN)
  • Women & Children's Health Research Institute (WCHRI)

Zitieren

APA

Suarez, R. G. S., McClement, D. G., Vega, R., Huynh, H. Q., Shaikh, A., Otley, A., Jacobson, K., Sherlock, M., Mack, D. R., Deslandres, C., El-Matary, W., Crowley, E., deBruyn, J., Walters, T., Griffiths, A. M., Greiner, R., Eytan Wine, & Canadian Children IBD Network (2026). Using machine learning to predict clinical remission with exclusive enteral nutrition in pediatric Crohn disease. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70299

Vancouver

Suarez RGS, McClement DG, Vega R, Huynh HQ, Shaikh A, Otley A, et al. Using machine learning to predict clinical remission with exclusive enteral nutrition in pediatric Crohn disease. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70299

BibTeX
@article{Suarez2026,
  author = {Suarez, Ricardo G Suarez and McClement, Daniel G and Vega, Roberto and Huynh, Hien Q and Shaikh, Ayub and Otley, Anthony and Jacobson, Kevan and Sherlock, Mary and Mack, David R and Deslandres, Colette and El-Matary, Wael and Crowley, Eileen and deBruyn, Jennifer and Walters, Thomas and Griffiths, Anne M and Greiner, Russell and Eytan Wine and Canadian Children IBD Network, Canadian Children IBD Network},
  title = {Using machine learning to predict clinical remission with exclusive enteral nutrition in pediatric Crohn disease},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  doi = {10.1002/jpn3.70299}
}
Kostenlos starten →